Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR

Post time 2026-7-23 22:15:01

journal：Journal of Medicinal Chemistry

Authors：Hubert Josien; Anilkumar G. Nair; Fa-Xiang Ding; Yan Guo; Yi-Heng Chen; Ashwin U. Rao; Jian Liu; Ling Tong; Zhongxiang Sun; Michael M.-C. Lo; Thomas J. Tucker; Mark W. Embrey; Aurash Shahripour; Chengwei Wu; Elisabetta Bianchi; Danila Branca; Jeffrey T. Kuethe; Joshua Lee; David A. Thaisrivongs; Paul G. Bulger; Xiaohong Zhu; Sookhee N. Ha; Jennifer M. Johnston; Daniel J. Klein; Peter Orth; Mee Ra Hong; Alexei V. Buevich; Qi Gao; Hratch J. Zokian; Kenneth A. Koeplinger; Rodger W. Tracy; Michael J. Hafey; Nicole Buist; Tjerk Bueters; Candice Alleyne; Alan Bass; Louis-Charles Campeau; Douglas G. Johns; Robert M. Garbaccio; Petr Vachal; Abbas Walji; Harold B. Wood

Published date：2026-6-11

DOI：10.1021/acs.jmedchem.6c00463

PDF link：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6c00463

Article link：https://doi.org/10.1021/acs.jmedchem.6c00463

Article Source：American Chemical Society (ACS)。

Remark：

Post time 2026-7-23 22:15:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

[ACS] Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[ACS] Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR